Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma.

Toguchida J, Yamaguchi T, Dayton SH, Beauchamp RL, Herrera GE, Ishizaki K, Yamamuro T, Meyers PA, Little JB, Sasaki MS, et al.

N Engl J Med. 1992 May 14;326(20):1301-8.

2.

Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms.

Malkin D, Jolly KW, Barbier N, Look AT, Friend SH, Gebhardt MC, Andersen TI, Børresen AL, Li FP, Garber J, et al.

N Engl J Med. 1992 May 14;326(20):1309-15. Erratum in: N Engl J Med. 1997 Mar 6;336(10):734.

3.

High frequency of germline p53 mutations in childhood adrenocortical cancer.

Wagner J, Portwine C, Rabin K, Leclerc JM, Narod SA, Malkin D.

J Natl Cancer Inst. 1994 Nov 16;86(22):1707-10.

PMID:
7966399
4.

Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations.

Gonzalez KD, Noltner KA, Buzin CH, Gu D, Wen-Fong CY, Nguyen VQ, Han JH, Lowstuter K, Longmate J, Sommer SS, Weitzel JN.

J Clin Oncol. 2009 Mar 10;27(8):1250-6. doi: 10.1200/JCO.2008.16.6959. Epub 2009 Feb 9.

PMID:
19204208
5.

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.

Malkin D, Li FP, Strong LC, Fraumeni JF Jr, Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff FZ, Tainsky MA, et al.

Science. 1990 Nov 30;250(4985):1233-8. Erratum in: Science. 1993 Feb 12;259(5097):878.

PMID:
1978757
7.

Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families.

Birch JM, Hartley AL, Tricker KJ, Prosser J, Condie A, Kelsey AM, Harris M, Jones PH, Binchy A, Crowther D, et al.

Cancer Res. 1994 Mar 1;54(5):1298-304.

8.

Germline p53 gene mutations in subsets of glioma patients.

Kyritsis AP, Bondy ML, Xiao M, Berman EL, Cunningham JE, Lee PS, Levin VA, Saya H.

J Natl Cancer Inst. 1994 Mar 2;86(5):344-9.

PMID:
8308926
9.

Sarcomas in TP53 germline mutation carriers: a review of the IARC TP53 database.

Ognjanovic S, Olivier M, Bergemann TL, Hainaut P.

Cancer. 2012 Mar 1;118(5):1387-96. doi: 10.1002/cncr.26390. Epub 2011 Aug 11. Review.

10.

P53 gene mutations in women with breast cancer and a previous history of benign breast disease.

Seth A, Palli D, Mariano JM, Metcalf R, Venanzoni MC, Bianchi S, Kottaridis SD, Papas TS.

Eur J Cancer. 1994;30A(6):808-12.

PMID:
7917542
11.

Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome.

Srivastava S, Zou ZQ, Pirollo K, Blattner W, Chang EH.

Nature. 1990 Dec 20-27;348(6303):747-9.

PMID:
2259385
12.

Germ-line mutations of the p53 tumor suppressor gene in patients with high risk for cancer inactivate the p53 protein.

Frebourg T, Kassel J, Lam KT, Gryka MA, Barbier N, Andersen TI, Børresen AL, Friend SH.

Proc Natl Acad Sci U S A. 1992 Jul 15;89(14):6413-7.

13.

Analysis of p53 tumor suppressor gene in families with multiple glioma patients.

Paunu N, Syrjäkoski K, Sankila R, Simola KO, Helén P, Niemelä M, Matikainen M, Isola J, Haapasalo H.

J Neurooncol. 2001 Dec;55(3):159-65.

PMID:
11859970
14.

Two germ-line mutations affecting the same nucleotide at codon 257 of p53 gene, a rare site for mutations.

Mazoyer S, Lalle P, Moyret-Lalle C, Marçais C, Schraub S, Frappaz D, Sobol H, Ozturk M.

Oncogene. 1994 Apr;9(4):1237-9.

PMID:
8134127
15.

Splice-site mutation of the p53 gene in a family with hereditary breast-ovarian cancer.

Jolly KW, Malkin D, Douglass EC, Brown TF, Sinclair AE, Look AT.

Oncogene. 1994 Jan;9(1):97-102.

PMID:
8302608
16.

[Germline mutations of the p53 gene].

Frebourg T.

Pathol Biol (Paris). 1997 Dec;45(10):845-51. Review. French.

PMID:
9769948
17.

Exclusion of a p53 germline mutation in a classic Li-Fraumeni syndrome family.

Evans SC, Mims B, McMasters KM, Foster CJ, deAndrade M, Amos CI, Strong LC, Lozano G.

Hum Genet. 1998 Jun;102(6):681-6.

PMID:
9703430
18.

Screening for germline p53 mutations in pediatric and adult patients of high-risk groups in Poland.

Fiszer-Maliszewska L, Czernik J, Sawicz-Birkowska K, Perek D, Kozera M, Wojciechowska B, Kazanowska B, Hudziec P, Kilar E.

Arch Immunol Ther Exp (Warsz). 2000;48(4):309-15.

PMID:
11059649
19.

Novel germline mutation of the p53 tumor suppressor gene in a child with incidentally discovered adrenal cortical carcinoma.

Grayson GH, Moore S, Schneider BG, Saldivar V, Hensel CH.

Am J Pediatr Hematol Oncol. 1994 Nov;16(4):341-7.

PMID:
7978053
20.

Rapid development of post-radiotherapy sarcoma and breast cancer in a patient with a novel germline 'de-novo' TP53 mutation.

Salmon A, Amikam D, Sodha N, Davidson S, Basel-Vanagaite L, Eeles RA, Abeliovich D, Peretz T.

Clin Oncol (R Coll Radiol). 2007 Sep;19(7):490-3. Epub 2007 Jun 14.

PMID:
17572079

Supplemental Content

Support Center